Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 14, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$27.8B
sum of reported positions
Reported positions
934
Changes vs prior quarter
1068
158 new · 177 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 342 measured positions in 8 quarters, the typical new or larger position finished −3.7 pts against the S&P 500 and 39% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.
Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $23.8B | $27.8B |
| Positions | 953 | 934 |
| Biggest line | — | NVIDIA 6% |
| 656K |
| $757M |
| 2.7% |
| 1.74M | $648M | 2.3% |
| 1.73M | $521M | 1.9% |
| 2.22M | $396M | 1.4% |
| 2.56M | $394M | 1.4% |
| 1.62M | $386M | 1.4% |
| 482K | $368M | 1.3% |
| 2.18M | $316M | 1.1% |
| 2.27M | $296M | 1.1% |
| 3.4M | $296M | 1.1% |
| 145K | $287M | 1.0% |
| 3.49M | $269M | 1.0% |
| 117K | $265M | 1.0% |
| 2.77M | $251M | 0.9% |
| 914K | $238M | 0.9% |
| 284K | $236M | 0.8% |
| 921K | $232M | 0.8% |
| 533K | $231M | 0.8% |
| 606K | $229M | 0.8% |
| 3.42M | $219M | 0.8% |
| 4.14M | $213M | 0.8% |
| 448K | $200M | 0.7% |
Howard Hughes (HHH)
74K → 27K shares (−63%)
Cogent Biosciences (COGT)
50K shares
Supernus Pharmaceuticals, Inc. (SUPN)
43K → 42K shares (−3%)
Savers Value Village (SVV)
191K shares
Latham Group (SWIM)
439K → 298K shares (−32%)
Owlet (OWLT)
72K → 331K shares (+361%)
Donegal Group (DGICA)
129K → 100K shares (−23%)
Lexington Realty Trust (LXP)
35K shares
National Bank Holdings Corporation (NBHC)
48K → 42K shares (−12%)
Allegro MicroSystems (ALGM)
308K → 27K shares (−91%)
Harrow (HROW)
44K shares
Viridian Therapeutics, Inc. (VRDN)
101K shares
Borr Drilling (BORR)
450K shares
Mistras Group (MG)
114K → 106K shares (−8%)
NOV Inc. (NOV)
100K shares
Highwoods Properties (HIW)
50K → 61K shares (+21%)
Sight Sciences (SGHT)
328K → 338K shares (+3%)
Titan International (TWI)
237K shares
Capital City Bank Group (CCBG)
40K → 37K shares (−8%)
G-III Apparel Group, Ltd. (GIII)
24K → 53K shares (+121%)
Bcb Bancorp (BCBP)
69K → 165K shares (+137%)
Core Scientific, Inc. (CORZ)
220K → 69K shares (−69%)
Tompkins Financial Corporation (TMP)
23K → 19K shares (−19%)
Upstream Bio (UPB)
253K shares
BioLife Solutions, Inc. (BLFS)
11K → 62K shares (+457%)
